Patent landscape of nanotechnology - based nucleic acid delivery systems for breast cancer therapies.

Silva MJ, Saraiva Hodel KV, Fonseca LDSM, da Hora HS, Murari TB, Pinto CD, Machado BAS

Open source

DOI
10.3389/fonc.2025.1702392
Published
2025
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2025.1702392,
  title = {Patent landscape of nanotechnology - based nucleic acid delivery systems for breast cancer therapies.},
  author = {Silva MJ and Saraiva Hodel KV and Fonseca LDSM and da Hora HS and Murari TB and Pinto CD and Machado BAS},
  year = {2025},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2025.1702392},
  url = {https://doi.org/10.3389/fonc.2025.1702392}
}

RIS

TY  - JOUR
TI  - Patent landscape of nanotechnology - based nucleic acid delivery systems for breast cancer therapies.
AU  - Silva MJ
AU  - Saraiva Hodel KV
AU  - Fonseca LDSM
AU  - da Hora HS
AU  - Murari TB
AU  - Pinto CD
AU  - Machado BAS
PY  - 2025
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2025.1702392
UR  - https://doi.org/10.3389/fonc.2025.1702392
ER  - 

APA

MJ, S., KV, S. H., LDSM, F., HS, D. H., TB, M., CD, P., & BAS, M. (2025). Patent landscape of nanotechnology - based nucleic acid delivery systems for breast cancer therapies.. Frontiers in oncology. https://doi.org/10.3389/fonc.2025.1702392

Source records